News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

MultiCell Technologies Inc. (MUCL) Licensee Markets Immortalized Cell Lines At American Association of Pharmaceutical Scientists


10/19/2005 5:09:02 PM

MultiCell Technologies, Inc. (OTCBB:MUCL), leading supplier of functional non-tumorigenic immortalized human hepatocyte lines Fa2n-4 and EA1C-35, announced that XenoTech LLC, its marketing and manufacturing licensee, presented MultiCell's cells at the American Association of Pharmaceutical Scientists meeting November 7th - 11th in Baltimore, MD. This year's annual meeting was the highest-attended AAPS event ever, with over 4,500 registrations and over 450 exhibitors.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES